Ways2Capital Reviews : Dr Reddy’s Gains 4% On Inspection Closures Report From USFDA For Duvada Facility

Shares of Dr Reddy’s gained 4% in Monday’s morning trade as the company received an inspection closure report from the United States Foo...
Read More

Ways2Capital Reviews : Dr Reddy’s Gets Warning Letter Relief While Biocon Gets Form 483

Dr. Reddy’s Lab has said that USFDA has lifted a warning letter on its formulations manufacturing facility at Duvvada. This site was inc...
Read More

Ways2Capital Reviews : Glenmark Pharma Gets USFDA Nod For Clobetasol Propionate Foam

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the USFDA for Clobetasol Propionate Foam, 0.05%, a gene...
Read More

Ways2Capital Reviews : Biocon Facilities Complete Pre-Approval USFDA Inspections With No Form 483

Biocon, in its press note to the exchanges on Monday, informed that the United States Food and Drug Administration (USFDA) concluded two...
Read More

Ways2Capital Reviews : BPCL Unit Signs Pact For 1 MMTPA Of LNG For 15 Years

Bharat Gas Resources Ltd, a wholly owned subsidiary of Bharat Petroleum Corporation Ltd. (BPCL) has executed a long term LNG Sale Purcha...
Read More

Ways2Capital Reviews : SEBI Grants Waiver For Wipro’s Buyback Offer

Wipro, in its filing to the exchanges, informed that the Securities and Exchange Board of India (SEBI) granted certain exemptions to the...
Read More

Ways2Capital Reviews : SPARC Parent Unit Not To Launch Elepsia As CNS

Sun Pharma Advanced Research Company Ltd (SPARC) has received a communication from Sun Pharma Global FZE (SPGFZE), a wholly owned subsid...
Read More

Ways2Capital Reviews : Asian Markets Trade Higher On US-China Trade Talks

Asian stock markets were trading higher on Monday morning, with trade talks between the US and China set to continue in Washington this...
Read More